D. Dalley
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
- Otorhinolaryngology top 5%
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 3
-
- Gastric Cancer Management and Outcomes 3
- Sarcoma Diagnosis and Treatment 3
-
- Colorectal and Anal Carcinomas 3
- Testicular diseases and treatments 3
D. Dalley
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Oncology 858
- Otorhinolaryngology 77
- Reproductive Medicine 127
- Pulmonary and Respiratory Medicine 398
- Pediatrics, Perinatology and Child Health 228
Countries citing papers authored by D. Dalley
This map shows the geographic impact of D. Dalley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dalley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dalley more than expected).
Fields of papers citing papers by D. Dalley
This network shows the impact of papers produced by D. Dalley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dalley. The network helps show where D. Dalley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Dalley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 24 | |
| 2 | 2012 | 180 | |
| 3 | 2008 | 23 | |
| 4 | 2008 | 4 | |
| 5 | 2004 | 52 | |
| 6 | 2000 | 9 | |
| 7 | 1997 | 63 | |
| 8 | 1993 | 96 | |
| 9 | 1992 | 2 | |
| 10 | 1989 | 12 | |
| 11 | 1989 | 19 | |
| 12 | 1989 | 2 | |
| 13 | 1988 | 6 | |
| 14 | 1982 | 18 | |
| 15 | 1981 | 68 | |
| 16 | 1981 | 2 | |
| 17 | Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract. | 1981 | 8 |
| 18 | 1981 | 4 | |
| 19 | 1980 | 2 | |
| 20 | 1979 | 42 |
About D. Dalley
D. Dalley is a scholar working on Otorhinolaryngology, Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Colorectal and Anal Carcinomas (3 papers), Gastric Cancer Management and Outcomes (3 papers), Testicular diseases and treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (858 citations), Otorhinolaryngology (77 citations), Reproductive Medicine (127 citations), Pulmonary and Respiratory Medicine (398 citations) and Pediatrics, Perinatology and Child Health (228 citations). D. Dalley has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include R. S. Aroney, John A. Levi, P Selby, Norman F. Boyd, JA Chapman, Anne Capp, Belinda Thewes, Robyn L. Ward, Michael Friedländer and Gareth J. Morgan. Their work appears in journals such as The Medical Journal of Australia, Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.